Abstract: A method of preparing a smokable cannabis-based product with reduced psychoactive effects and method for producing the same, comprising the steps of: (a) separating portions with known low tetrahydrocannabinol content from harvested plant material of the cannabis; (b) separating plant matter which has previously been used in a cannabis oil extraction process; (c) combining specific amounts of the separated materials to produce a cannabis plant material mixture possessing a specific active cannabis compound profile using a mixing device; and (d) loading the mixture of cannabis plant material into the cylindrical smokable tube using a loading device.

Abstract: A class of medically-effective formulations comprising cannabinoids, and terpenes, using ?-myrcene to improve effectiveness. B-myrcene decreases resistance across the blood-brain barrier for both itself and a plurality of other medically-active compounds such as other terpenes, cannabinoids, and flavonoids. Further, ?-myrcene has been determined to raise the saturation level of the cannabinoid receptor CB1 for phytocannabinoids such as delta(9)-tetrahydrocannabinol, and to increase cell membrane permeability for itself as well as cannabinoids, terpenes, flavonoids and other naturally occurring cannabis compounds, thereby improving therapeutic benefits of cannbis formulations.